Photo courtesy: The Indian Express
New Delhi: Eminent Indian virologist, Gagandeep Kang is skeptical about the Centre’s claim that it will get over 2 billion doses of vaccine from August to December. The production capacity of vaccine makers such as Serum Institute and Bharat Biotech is yet to ramp up, she said.
There is also no sufficient data to show the efficacy of Bharat Biotech’s nasal vaccine and Zydus Cadila’s DNA vaccine, she told Moneycontrol in an exclusive interview.
“I take the projections with a grain of salt. If you remember, last year, we were told that, by December, Serum Institute would produce 100 million doses of vaccine and Bharat Biotech in tens of millions of doses. There was going to be a large stockpile that was available with them. As we have found, that is not the case,” Kang told Moneycontrol.
It may be recalled that some states have floated global tenders for procuring a total of 121 million vaccine doses.
Mumbai: In his illustrious career, which is still going strong at the age of 81, Amitabh…
Berhampur: Police have arrested a youth for allegedly impregnating a minor girl on false promise…
Bhubaneswar: The Karnataka State Road Transport Corporation (KSRTC) will soon commence high-tech 'Ambaari Utsav' bus…
New Delhi: A category 1 storm hit the Shanghai region Monday, causing significant damage. Typhoon Bebinca…
New Delhi: Monday brought the news of yet another derailment on Indian rail tracks. Three…
Bhubaneswar: In a major move to enhance railway infrastructure in Odisha, Prime Minister Narendra Modi…
Bhubaneswar: In a bid to set an example for others, Excise officials destroyed a huge…
Hyderabad: Amid the renewed #MeToo wave in the southern film industry, another serious charge of…